Pioneering Addiction Psychiatrist Mitchell Rosenthal Dead at 87

Dr. Mitchell Rosenthal Mitchell Rosenthal, MD, the founder and long-time president and CEO of Phoenix House, a nonprofit substance use disorder treatment organization, died on November 17 at the age of 87. The psychiatrist died at a Manhattan hospital from complications of pneumonia, The New York Times reports. Rosenthal was a dedicated advocate of ensuring … Read more

Childhood Adversity Tied to CVD in Early Adulthood

Children who experience adversity ― including serious family illness or death, poverty, neglect, or dysfunctional and stressful family relationships ― are at increased risk of developing cardiovascular disease (CVD) in early adulthood, a large Danish study has found. Compared to young adults who experienced little adversity in childhood, peers who experienced high levels of childhood … Read more

Primary Care Moves Patients With Addiction to Self-Advocacy

Samuel Werner, DO, a family medicine physician in West Hartford, Connecticut, vividly remembers one patient who was struggling with a drug addiction. The man was having trouble holding down a steady job because of his dependence, but with Werner’s guidance, he started on buprenorphine. Werner also connected him with a social worker to address housing … Read more

SUD History Tied to Increased Risk of Death From Other Illnesses

Patients hospitalized for substance use disorder (SUD) are significantly more likely to die from other medical conditions later in life, a new study suggests. Researchers looked at mortality following a diagnosis of 28 different medical conditions, including heart failure, cancer, diabetes, multiple sclerosis, and stroke, and found patients with a history of alcohol or drug … Read more

Naloxone May Fail for Overdoses Tainted With ‘Tranq,’ FDA Warns

The US Food and Drug Administration (FDA) is alerting healthcare professionals about the special management required for opioid overdoses tainted with xylazine, an animal tranquilizer known on the street as tranq, tranq dope, sleep-cut, Philly dope, and zombie drug. The tranquilizer is often combined with fentanyl or heroin, or occasionally with a stimulant, said the … Read more

Four Commonly Abused Drugs Linked With Atrial Fibrillation

Cocaine, methamphetamine, opioids, and cannabis may independently increase the risk of atrial fibrillation (AFib), based on data from almost 24 million people. While more work is needed to uncover causal links, physicians should be aware that these commonly abused substances could be driving new cases of AFib, reported investigators from the University of California, San … Read more

‘The Kids Are Not Alright’

A new report shines a light on the toll the pandemic and other stressors have taken on the mental health of US children and adolescents over the last 6 years. The report shows a dramatic increase in use of acute care services for depression, anxiety, and other mental health conditions, especially among teens and preteens. … Read more

Expert Views on Psychoactive Drugs at Odds With US Policy

Psychiatrists’ perceptions of the safety, therapeutic value, and abuse potential of psychoactive drugs are inconsistent with current drug policy, results from a new survey show. Adam Levin, MD “The consensus among experts, including psychiatrists, about specific drugs is not consistent or congruent with the schedule of these drugs” in the United States, lead author Adam … Read more

They Call It ‘Tranq,’ and It’s Making Street Drugs More Dangerous

Approaching a van that distributes supplies for safer drug use in Greenfield, Massachusetts, a man named Kyle noticed an alert about xylazine. “Xylazine?” he asked, sounding out the unfamiliar word. “Tell me more.” Tapestry Health Systems nurse Katy Robbins hands bottles of water to Kyle as he visits the harm reduction mobile unit in Greenfield, … Read more

Electroacupuncture Promising for Depression-Related Insomnia

Electroacupuncture (EA) may significantly improve sleep quality in patients with depression who also have insomnia, new research suggests. In a study of more than 200 adults with depression and comorbid insomnia, change from baseline to week 8 on the Pittsburgh Sleep Quality Index (PSQI) was 3 points greater in the group receiving EA vs a … Read more